J.M. Vannetzel

422 total citations
10 papers, 220 citations indexed

About

J.M. Vannetzel is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Genetics. According to data from OpenAlex, J.M. Vannetzel has authored 10 papers receiving a total of 220 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 3 papers in Oncology and 2 papers in Genetics. Recurrent topics in J.M. Vannetzel's work include Advanced Breast Cancer Therapies (2 papers), Estrogen and related hormone effects (2 papers) and Breast Cancer Treatment Studies (2 papers). J.M. Vannetzel is often cited by papers focused on Advanced Breast Cancer Therapies (2 papers), Estrogen and related hormone effects (2 papers) and Breast Cancer Treatment Studies (2 papers). J.M. Vannetzel collaborates with scholars based in France, United States and Japan. J.M. Vannetzel's co-authors include J.F. Méder, Bernard Escudier, F.-X. Roux, F. Nataf, Zhihua Liu, E. Touboul, Michel Schlienger, J. L. Misset, Sarah Mackenzie and Stéphane Culine and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

J.M. Vannetzel

9 papers receiving 212 citations

Peers

Countries citing papers authored by J.M. Vannetzel

Since Specialization

Citations

This map shows the geographic impact of J.M. Vannetzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.M. Vannetzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.M. Vannetzel more than expected).

Fields of papers citing papers by J.M. Vannetzel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.M. Vannetzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.M. Vannetzel. The network helps show where J.M. Vannetzel may publish in the future.

Co-authorship network of co-authors of J.M. Vannetzel

This figure shows the co-authorship network connecting the top 25 collaborators of J.M. Vannetzel. A scholar is included among the top collaborators of J.M. Vannetzel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.M. Vannetzel. J.M. Vannetzel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Age Specific Competing Mortality In Breast Cancer Patients - a TEAM Study Analysis 2011 ·Data Archiving and Networked Services (DANS) ·Christos Markopoulos, (unknown), Hein Putter, (unknown), Annette Hasenburg, (unknown), J.M. Vannetzel, Robert Paridaens, Didier van de Velde, (unknown)	0
2	5015 ORAL Age Specific Competing Mortality in Breast Cancer Patients -a TEAM Study Analysis 2011 ·European Journal of Cancer ·Christos Markopoulos, W. van de Water, Hein Putter, C. Seynaeve, Annette Hasenburg, D. Rea, J.M. Vannetzel, Robert Paridaens, Cornelis J.�H. van de Velde, (unknown)	1
3	2BA Results of the TEAM (tamoxifen exemestane adjuvant multinational) prospective randomized phase III trial in hormone sensitive postmenopausal early breast cancer 2009 ·European Journal of Cancer Supplements ·(unknown), Caroline Seynaeve, Annette Hasenburg, Daniel Rea, J.M. Vannetzel, Robert Paridaens, Christos Markopoulos, Jan Smeets, J.W.R. Nortier, (unknown)	8
4	Five Years of Exemestane as Initial Therapy Compared to 5 Years of Tamoxifen Followed by Exemestane: The TEAM Trial, a Prospective, Randomized, Phase III Trial in Postmenopausal Women with Hormone-Sensitive Early Breast Cancer. 2009 ·Cancer Research ·Daniel Rea, Annette Hasenburg, C. Seynaeve, SE Jones, J.M. Vannetzel, Robert Paridaens, Christos Markopoulos, Yasuo Hozumi, Hein Putter, E.T.M. Hille, Lina Asmar, (unknown), (unknown), John M.S. Bartlett, Jan Smeets, (unknown)	31
5	Radiosurgery With or Without A 2-mm Margin for 93 Single Brain Metastases 2008 ·International Journal of Radiation OncologyBiologyPhysics ·F. Nataf, Michel Schlienger, Zhihua Liu, (unknown), (unknown), (unknown), J.M. Vannetzel, Bernard Escudier, J.F. Méder, F.-X. Roux, E. Touboul	74
6	Trastuzumab (T) combined with standard chemotherapy in HER+ metastatic bladder cancer (BC) patients: Interim safety results of a prospective randomized phase II study 2007 ·Journal of Clinical Oncology ·Philippe Beuzeboc, Eugéniu Banu, Éric Voog, Guilhem Bousquet, Frank Priou, G. Deplanque, Laurence Bozec, J-P. Machiels, J.M. Vannetzel, Stéphane Oudard	12
7	Phase II study of oxaliplatin versus oxaliplatin combined with infusional 5-fluorouracil in hormone refractory metastatic prostate cancer patients 2003 ·Annals of Oncology ·Jean‐Pierre Droz, Xavier Muracciole, Nicolas Mottet, (unknown), J.M. Vannetzel, Nicolas Albin, Stéphane Culine, (unknown), J. L. Misset, Sarah Mackenzie, Esteban Cvitkovic, G Benoît	33
8	Phase II Study of Oxaliplatin and Fluorouracil in Taxane- and Anthracycline-Pretreated Breast Cancer Patients 2002 ·Journal of Clinical Oncology ·Laurent Zelek, Paul Cottu, M. Tubiana-Hulin, J.M. Vannetzel, P. Chollet, J. L. Misset, Nadia Chouaki, M. Marty, Érick Gamelin, Stéphane Culine, Véronique Dièras, Sarah Mackenzie, M. Spielmann	44
9	104 The five year results of a randomized trial of sequential versus concomitant cisplatin and fluorouracil and radiation in advanced head and neck cancer 1995 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Anantha Murthy, J.M. Vannetzel, M.S. Kies, Bharat B. Mittal, John Showel, (unknown), (unknown), P. Colin, (unknown), Carol Blendowski, (unknown)	1
10	Phase II trial of D-Trp-6-LH-RH in advanced breast cancer 1986 ·European Journal of Cancer and Clinical Oncology ·G Mathé, (unknown), (unknown), J Gastiaburu, (unknown), J.M. Vannetzel, Raymond Despax, C Jasmin, Fabio Levi, M Musset, D. Machover, J.L. Misset	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact